(PharmaNewsWire.Com, August 10, 2019 ) The US Veterinary Infusion Pumps market factors such as the growing demand for pet insurance and increasing animal healthcare expenditure, rising demand for animal-derived food products, and growth in the number of veterinary practitioners and their income levels are the primary growth drivers.
This report analyzes the market by type and end user. On the basis of type, the market is segmented into large-volume infusion pumps and syringe infusion pumps. In 2015, the large-volume infusion pumps segment accounted for the largest market share, primarily due to the increasing use of these pumps for delivering large volumes of fluids to animals during emergency conditions, providing blood transfusions, and administering total parenteral nutrition at continuous predetermined medium-to-high flow rates.
Based on end user, the market is segmented into private hospitals accounted for the largest share, majorly due to the increasing use of large-volume infusion pumps and syringe infusion pumps to administer fluids for various clinical conditions in animals, and growth in animal health expenditure.
DRE Veterinary (U.S.) and Jorgensen Laboratories (U.S.) hold the major share of the veterinary infusion pumps market and will continue to dominate the market between 2016 and 2021.
Some of the other players operating in this market are Heska Corporation (U.S.), Digicare Biomedical Technology Inc. (U.S.), B. Braun Melsungen AG (Germany), Q Core Medical Ltd. (Israel), Grady Medical System Inc. (U.S.), Mediaid Inc. (U.S.), Burtons Medical Equipment Ltd. (U.K.), Jørgen Kruuse A/S (Denmark), and Kent Scientific Corporation (U.S.).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
